Immune Pharmaceuticals (IMNPQ) News Today → The ONE AI sSock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free IMNPQ Stock Alerts $0.0010 0.00 (0.00%) (As of 08/17/2022) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJ&J's immune disorder drug succeeds in studiesreuters.com - February 5 at 9:59 AMAC Immune: Initial AD Findings Bring About Two Upcoming Catalystsseekingalpha.com - December 20 at 4:40 PMBest Vitamins And Foods To Boost Your Immune Systemforbes.com - December 20 at 4:40 PMAC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trialmarkets.businessinsider.com - December 15 at 1:14 PMRegeneron’s Veopoz scores FDA approval for rare immune diseasemsn.com - August 21 at 4:25 PMFDA Approves Regeneron's Drug For Ultra Rare Immune Disordermsn.com - August 21 at 4:25 PMRegeneron wins approval for rare immune disease therapy pozelimabseekingalpha.com - August 18 at 4:25 PMNatural Immune Booster Market to Reach $19.67 Billion by 2030, Says Coherent Market Insights (CMI)benzinga.com - July 28 at 1:59 PMImmune Check Point Inhibitor Market Size, Latest Trends, Key Players, Revenue, Report, And Forecast 2031marketwatch.com - April 22 at 5:49 PMHuman Immune Health Supplements Market Size and New Revenue Techniques By 2031marketwatch.com - March 28 at 9:41 AMNatural Immune Booster Market Top Players By 2031marketwatch.com - March 24 at 9:49 AMJudge: Oxford Schools, Staff Immune From Shooting Lawsuitsusnews.com - March 6 at 6:00 AMImmune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Directionbenzinga.com - March 1 at 12:21 PMGlobal Natural Immune Booster Market Report Historical, Current, and Projected Size, in terms of value 2030 By VMReportsmarketwatch.com - February 28 at 7:41 AMChelsea Handler declares she's immune to cancel culture because she's not ‘racist,’ ‘sexist’ ‘idiot’foxnews.com - January 14 at 5:15 PMStudy shows convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to findcnn.com - January 14 at 5:15 PMImmune system-evading hybrid virus observed for first timetheguardian.com - October 27 at 6:33 PMFor those with HIV or weak immune systems, monkeypox can be fatal -U.S. studyreuters.com - October 26 at 6:41 PMTargeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studiesyahoo.com - October 25 at 5:37 PMPositive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published in NEJMmarkets.businessinsider.com - September 12 at 4:54 AMCour Pharmaceuticals secures funding to transform the way allergies and autoimmune disorders are treatedbizjournals.com - September 7 at 7:12 PMLogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updatemarkets.businessinsider.com - August 15 at 8:04 AMIMNPQ.PK - | Stock Price & Latest News | Reutersreuters.com - August 14 at 10:02 PMImmune Pharmaceuticals (OTC:IMNPQ), Analyst Ratings, Price Targets, Predictionsbenzinga.com - August 9 at 10:38 PMImmune Pharmaceuticals, Inc. (IMNPQ)finance.yahoo.com - July 16 at 8:47 PMVBL Therapeutics Receives FDA Fast Track Designation for Ofra-Vec for the Treatment of Platinum-Resistant Ovarian Cancerapnews.com - April 26 at 12:33 PMImmune Pharmaceuticals Inc.barrons.com - August 28 at 9:33 PM Get Immune Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNPQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy IMNPQ Media Mentions By Week IMNPQ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNPQ News Sentiment▼0.000.62▲Average Medical News Sentiment IMNPQ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNPQ Articles This Week▼00▲IMNPQ Articles Average Week Get Immune Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNPQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADCT News IMUC News LVTX News MYNZ News OPHLF News PHVS News PVTTF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMNPQ) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immune Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.